SynopsisThe global market for Mitomycin was valued at US$ 191 million in the year 2024 and is projected to reach a revised size of US$ 333 million by 2031, growing at a CAGR of 8.4% during the forecast period. Mitomycin is an antibiotic which acts as a double-st.....
SynopsisThe global market for Thrombolytic Therapy was valued at US$ 33880 million in the year 2024 and is projected to reach a revised size of US$ 39100 million by 2031, growing at a CAGR of 2.1% during the forecast period. The thrombolytic therapy market cover.....
SynopsisThe global market for ECG Electrodes was valued at US$ 409 million in the year 2024 and is projected to reach a revised size of US$ 504 million by 2031, growing at a CAGR of 3.1% during the forecast period. An electrocardiogram monitors your heart rhythm.....
SynopsisThe global market for Trach Securement Devices was valued at US$ 51 million in the year 2024 and is projected to reach a revised size of US$ 67.5 million by 2031, growing at a CAGR of 3.5% during the forecast period. A Trach Securement Device is a medica.....
SynopsisThe global market for Peptide CXO was valued at US$ 3211 million in the year 2024 and is projected to reach a revised size of US$ 6459 million by 2031, growing at a CAGR of 10.6% during the forecast period. Peptide CXO refers to the outsourcing of resear.....
SynopsisThe global market for Medical Smart Textile was valued at US$ 1038 million in the year 2024 and is projected to reach a revised size of US$ 4934 million by 2031, growing at a CAGR of 25.3% during the forecast period. The smart fabrics also famous as elec.....
SynopsisThe global market for Personal Emergency Response Systems (PERS) was valued at US$ 8524 million in the year 2024 and is projected to reach a revised size of US$ 12830 million by 2031, growing at a CAGR of 6.1% during the forecast period. Personal emergen.....
SynopsisThe global market for Veterinary Obstetric and Gynecological Ultrasound Imager was valued at US$ 512 million in the year 2024 and is projected to reach a revised size of US$ 781 million by 2031, growing at a CAGR of 6.2% during the forecast period. Veter.....
SynopsisThe global market for Human Bone Morphogenetic Protein 9 was valued at US$ 98 million in the year 2024 and is projected to reach a revised size of US$ 165 million by 2031, growing at a CAGR of 7.5% during the forecast period. Bone morphogenetic proteins .....
SynopsisThe global market for Clozapine was valued at US$ 379 million in the year 2024 and is projected to reach a revised size of US$ 507 million by 2031, growing at a CAGR of 4.3% during the forecast period. Clozapine is indicated in the management of symptoms.....
